| Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange H Abboud, A Petrak, M Mealy, S Sasidharan, L Siddique, M Levy Multiple Sclerosis Journal 22 (2), 185-192, 2016 | 138 | 2016 |
| Impact of mild cognitive impairment on outcome following deep brain stimulation surgery for Parkinson's disease H Abboud, D Floden, NR Thompson, G Genc, S Oravivattanakul, ... Parkinsonism & related disorders 21 (3), 249-253, 2015 | 39 | 2015 |
| Neuromodulation in multiple sclerosis H Abboud, E Hill, J Siddiqui, A Serra, B Walter Multiple Sclerosis Journal 23 (13), 1663-1676, 2017 | 29 | 2017 |
| Essential tremor: choosing the right management plan for your patient H Abboud, A Ahmed, HH Fernandez Cleve Clin J Med 78 (12), 821-8, 2011 | 27 | 2011 |
| Return of bradykinesia after subthalamic stimulation ceases: relationship to electrode location SE Cooper, AM Noecker, H Abboud, JL Vitek, CC McIntyre Experimental neurology 231 (2), 207-213, 2011 | 25 | 2011 |
| Comprehensive, multidisciplinary deep brain stimulation screening for Parkinson patients: no room for “short cuts” H Abboud, R Mehanna, A Machado, A Ahmed, M Gostkowski, S Cooper, ... Movement Disorders Clinical Practice 1 (4), 336-341, 2014 | 24 | 2014 |
| Iatrogenic CNS demyelination in the era of modern biologics N Kumar, H Abboud Multiple Sclerosis Journal 25 (8), 1079-1085, 2019 | 17 | 2019 |
| Predictors of functional and quality of life outcomes following deep brain stimulation surgery in Parkinson’s disease patients: disease, patient, and surgical factors H Abboud, G Genc, NR Thompson, S Oravivattanakul, F Alsallom, ... Parkinson’s Disease 2017, 2017 | 17 | 2017 |
| Multiple sclerosis disease-modifying therapy and the COVID-19 pandemic: implications on the risk of infection and future vaccination C Zheng, I Kar, CK Chen, C Sau, S Woodson, A Serra, H Abboud CNS drugs 34 (9), 879-896, 2020 | 14 | 2020 |
| Neuronal autoantibodies: differentiating clinically relevant and clinically irrelevant results H Abboud, I Rossman, MA Mealy, E Hill, N Thompson, A Banerjee, ... Journal of neurology 264 (11), 2284-2292, 2017 | 11 | 2017 |
| Socioeconomic Status M ay Impact Functional Outcome of Deep Brain Stimulation Surgery in P arkinson's Disease G Genc, H Abboud, S Oravivattanakul, F Alsallom, NR Thompson, ... Neuromodulation: Technology at the Neural Interface 19 (1), 25-30, 2016 | 10 | 2016 |
| Prevalence of asthma in multiple sclerosis: a United States population-based study E Hill, H Abboud, FBS Briggs Multiple sclerosis and related disorders 28, 69-74, 2019 | 9 | 2019 |
| Spinal Movement Disorders in Neuromyelitis Optica: An Under‐recognized Phenomenon H Abboud, HH Fernandez, MA Mealy, M Levy Movement disorders clinical practice 3 (6), 596-602, 2016 | 7 | 2016 |
| Unusual case of levodopa-responsive camptocormia in a patient with negative dopamine transporter scan and normal DYT 5 gene S Oravivattanakul, H Abboud, H Fernandez, I Itin Clinical neuropharmacology 37 (2), 63-64, 2014 | 7 | 2014 |
| Movement disorders in early MS and related diseases: A prospective observational study H Abboud, XX Yu, K Knusel, HH Fernandez, JA Cohen Neurology: Clinical Practice 9 (1), 24-31, 2019 | 6 | 2019 |
| Camptocormia and Pisa syndrome as manifestations of acute myasthenia gravis exacerbation H Abboud, I Sivaraman, D Ontaneda, J Tavee Journal of the neurological sciences 359 (1), 8-10, 2015 | 6 | 2015 |
| Triaging patients with multiple sclerosis in the emergency department: room for improvement H Abboud, K Mente, M Seay, J Kim, A Ali, R Bermel, MA Willis International journal of MS care 19 (6), 290-296, 2017 | 5 | 2017 |
| Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic H Abboud, C Zheng, I Kar, CK Chen, C Sau, A Serra Multiple sclerosis and related disorders, 102249, 2020 | 3 | 2020 |
| The pressing questions in multiple sclerosis Care in the era of COVID-19 H Abboud, A Serra Journal of the Neurological Sciences 416, 2020 | 2 | 2020 |
| Height and weight changes after deep brain stimulation in patients with Parkinson disease: role of clinical subtypes H Abboud, D Reyes, G Genc, A Ahmed, M Gostkowski, HH Fernandez Heliyon 5 (6), e01862, 2019 | 2 | 2019 |
